Profil
Michael Oredsson currently works at The Akkermansia Co., as Chief Executive Officer, Northern Lights Southern Cross AB, as Chief Executive Officer & Director, and Cyxone AB, as Chairman from 2023.
Mr. Oredsson also formerly worked at Nutri Pharma ASA, as Chief Executive Officer in 2001, Probi AB, as CEO & Investor Relations Officer from 2012 to 2013, Biosignal Ltd., as Chief Executive Officer in 2007, Biome Australia Ltd., as Chief Executive Officer, Mendus AB, as Chairman from 2018 to 2021, Mendus AB, as Chairman, Ectin Research AB, as Chairman, SP Sveriges Tekniska Forskningsinstitut AB, as Director, LIDDS AB, as Director from 2010 to 2011, and BioInvent International AB, as President from 2017 to 2018.
Mr. Oredsson received his undergraduate degree from the University of Lund.
Postes actifs de Michael Oredsson
| Sociétés | Poste | Début |
|---|---|---|
| CYXONE AB | Président | 01/01/2023 |
Northern Lights Southern Cross AB | Directeur Général | - |
A-Mansia Biotech SA (Belgium)
A-Mansia Biotech SA (Belgium) Pharmaceuticals: OtherHealth Technology Produces probiotic and postbiotic supplements | Directeur Général | - |
Anciens postes connus de Michael Oredsson
| Sociétés | Poste | Fin |
|---|---|---|
| MENDUS AB | Président | 22/01/2021 |
| BIOINVENT INTERNATIONAL AB | Directeur Général | 31/12/2017 |
| PROBI AB | Directeur Général | 24/05/2013 |
Biosignal Ltd.
Biosignal Ltd. Advertising/Marketing ServicesCommercial Services Provides media and artist agency services | Directeur Général | 01/01/2007 |
Nutri Pharma ASA
Nutri Pharma ASA Miscellaneous Commercial ServicesCommercial Services Engages in the development of soy technology for the treatment and prevention of life-style related diseases | Directeur Général | 01/01/2001 |
Formation de Michael Oredsson
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 13 |
|---|---|
Nutri Pharma ASA
Nutri Pharma ASA Miscellaneous Commercial ServicesCommercial Services Engages in the development of soy technology for the treatment and prevention of life-style related diseases | Commercial Services |
Probi AB
Probi AB BiotechnologyHealth Technology Develops patents probiotic strains for use in nutritional products | Health Technology |
BioInvent International AB
BioInvent International AB BiotechnologyHealth Technology Develops and manufactures immunomodulatory antibodies for cancer treatment | Health Technology |
University of Lund
University of Lund Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Biosignal Ltd.
Biosignal Ltd. Advertising/Marketing ServicesCommercial Services Provides media and artist agency services | Commercial Services |
SP Sveriges Tekniska Forskningsinstitut AB
SP Sveriges Tekniska Forskningsinstitut AB Miscellaneous Commercial ServicesCommercial Services Operates as a international research institute | Commercial Services |
LIDDS AB
LIDDS AB Pharmaceuticals: MajorHealth Technology Focuses on the development of treatment alternatives and hormonal therapy for prostate cancer | Health Technology |
Mendus AB
Mendus AB BiotechnologyHealth Technology Develops immunotherapies for therapeutic treatment of cancer | Health Technology |
Cyxone AB
Cyxone AB Pharmaceuticals: MajorHealth Technology Develops cyclotide drugs for autoimmune and other diseases | Health Technology |
A-Mansia Biotech SA (Belgium)
A-Mansia Biotech SA (Belgium) Pharmaceuticals: OtherHealth Technology Produces probiotic and postbiotic supplements | Health Technology |
Ectin Research AB
Ectin Research AB BiotechnologyHealth Technology Provides cancer therapy research services | Health Technology |
Biome Australia Ltd.
Biome Australia Ltd. Pharmaceuticals: MajorHealth Technology Develops and markets evidence-based complementary medicines, nutraceuticals & live bio-therapeutics | Health Technology |
Northern Lights Southern Cross AB |
















